Infliximab: a chimeric anti-TNF-αα monoclonal antibody for the treatment of ankylosing spondylitis and other spondyloarthritides

Author： Baeten Dominique  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.2, 2006-03, pp. : 191-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis

By                  

International Journal of Molecular Medicine, Vol. 33, Iss. 3, 2014-01 ,pp. : 711-721

Spandidos Publications

Access to resources Recommend Favorite

Issues in the Treatment of Ankylosing Spondylitis with Non-Steroidal Anti-Inflammatory Drugs

By van der Linden Sjef  

Wiener Medizinische Wochenschrift, Vol. 158, Iss. 7-8, 2008-05 ,pp. : 195-199

Springer Publishing Company

Access to resources Recommend Favorite

Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis

By Haberhauer Guenther  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 220-224

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 5, 2015-06 ,pp. : 548-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

A narrative literature review of the impact of anti-TNFα treatment on the occupational performance of people with rheumatoid arthritis or ankylosing spondylitis

By McArthur Margaret   Birt Linda   Goodacre Lynne  

The British Journal of Occupational Therapy, Vol. 76, Iss. 10, 2013-10 ,pp. : 456-469

College of Occupational Therapists

Access to resources Recommend Favorite